 role beta-blockade therapy ventricular tachycardia isoproterenol prospective analysis Isoproterenol ventricular tachycardia VT induction role beta-blockade treatment VT use beta-blockade consecutive patients isoproterenol S.D micrograms/min sustained monomorphic VT seconds termination due collapse negative baseline study VT mechanisms automaticity group patients automaticity group patients reentry group patients serial intravenous electropharmacologic tests propranolol mg/kg mg/kg propranolol verapamil group serial tests propranolol procainamide quinidine class Ia drug propranolol class Ia drug VT patients group group patient patients plus verapamil group patients patient class Ia drug patient class Ia drug follow-up S.D months VT patient patients propranolol substitution amiodarone due congestive heart failure patients isoproterenol VT induction beta-blockade effective reinduction VT enhanced automaticity heterogeneous response VT mechanisms automaticity reentry